Advanced Code injection

News & Press Releases

Featured
Press release logo Voyce HHSC.jpg
Voyce, Hamilton Health Sciences and OBIO® Showcase Breakthrough in Patient Care Through Language Access Technology
Read More →
Morphocell technologies.jpeg
Morphocell Technologies announces completion of US$40 Million Series A financing
Read More →
Rocket Doctor logo.png
Rocket Doctor selected for the inaugural cohort of the Google for Startups Accelerator
Read More →
1712692970065.jpeg
HDAX Therapeutics and Noa Therapeutics' CEOs selected among the 2024 Termeer Fellows
Read More →
hyivy health logo.2.jpeg
Hyivy Health featured in the Globe and Mail
Read More →
16Bit logo.png
16Bit receives FDA De Novo marketing authorization for Rho™
Read More →
Press release logo EAHN CHEO PolyUnity_2.jpg
CHEO selects PolyUnity for 3D Printing Solution
Read More →
Digital and Swift logos.png
DIGITAL and Swift Medical announce pioneering co-investment in AI for enhanced wound care
Read More →
ProteinQure logo.png
ProteinQure announces a breakthrough therapeutic in the fight against Triple-Negative Breast Cancer
Read More →
mDETECT logo.png
mDETECT featured in the National Post
Read More →
Conavi and Titan logos.png
Conavi and Titan Medical merge to help ignite widespread adoption of next-generation Novasight Hybrid intravascular imaging platform
Read More →
Screen Shot 2024-04-01 at 4.09.14 PM.png
Ontario biotech start-ups get government funding and business support
Read More →
Flosonics Medical logo.png
Flosonics Medical secures $20 million USD in Series C funding
Read More →
Press release logo AHS Trexo Robotics_no AHS.jpg
Through OBIO’s EAHN™, Trexo Plus Robotic Walker Enables Children with Physical Disabilities to Achieve Personalized Rehabilitation
Read More →
Tenomix logo.png
Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging
Read More →
Quthero logo.png
Quthero secures $500,000 investment boost from the Ontario Centre of Innovation
Read More →
Noa Therapeutics logo.png
Noa Therapeutics secures pre-Seed financing to transform the treatment of inflammatory disease
Read More →
Fusion and Astra Zeneca logo.png
Fusion Pharmaceuticals to be acquired by AstraZeneca, accelerating development of next-generation radioconjugates to treat cancer
Read More →
Domain and Chime Biologics.png
Domain Therapeutics and Chime Biologics join forces to advance novel anti-CCR8 antibody for cancer immunotherapy
Read More →
Cosm Medical logo.png
Cosm Medical achieves FDA clearance for Gynethotics™ Pessaries, pioneering the future of personalized pelvic care
Read More →
WiHI Mar 8_1_ed.jpg
OBIO® Celebrates International Women’s Day with Investment in Three Women-Led Companies and a Successful Graduation of First Seed Funding Cohort
Read More →
Press release logo FACIT-OBIO_new.jpg
FACIT and OBIO® partner on women-focused seed capital and entrepreneurship program
Read More →
Press release logo ToeFX Banwell.jpg
A Light at the End of the Toenail
Read More →
Tenomix logo.png
Tenomix secures an all-Canadian oversubscribed Seed round of $2M to advance a breakthrough cancer care robotics system
Read More →
Jenthera Therapeutics logo.png
Canadian technology that could transform how we treat cancer
Read More →
HDAX logo.png
HDAX among ten exciting U of T-affiliated start-ups to keep an eye on in 2024
Read More →
Vena Medical.png
More recognition for OBIO® member Vena Medical
Read More →
MIMOSA Diagnostics logo.png
MIMOSA Diagnostics receives Health Canada approval
Read More →
Mediphage logo.png
Mediphage Bioceuticals closes Seed round financing
Read More →
KA Imaging.png
KA Imaging to present on Portable Dual-Energy Tomosynthesis at ECR 2024
Read More →